Intravitreal triamcinolone acetonide for rebound phenomenon after high-dose intravenous steroid treatment in Vogt-Koyanagi-Harada disease

The authors report two cases of rebound phenomenon treated with intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada (VKH) disease. Patients in the acute phase of VKH disease were treated with high-dose intravenous (IV) methylprednisolone (1 g/day) for 3 days. Serous retinal detachment decre...

Descripción completa

Detalles Bibliográficos
Autores principales: Byon, Ik Soo, Kim, Ji Hun, Lee, Ji Eun, Oum, Boo Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218169/
https://www.ncbi.nlm.nih.gov/pubmed/22125406
http://dx.doi.org/10.2147/OPTH.S25477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218169/
https://www.ncbi.nlm.nih.gov/pubmed/22125406
http://dx.doi.org/10.2147/OPTH.S25477

Ejemplares similares